Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Depreciation & Amortization - Total: 2016-2018

Historic Depreciation & Amortization - Total for Fortress Biotech (FBIO) over the last 3 years, with Sep 2018 value amounting to $548,000.

  • Fortress Biotech's Depreciation & Amortization - Total rose 174.00% to $548,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $1.3 million, marking a year-over-year increase of 54.79%. This contributed to the annual value of $700,000 for FY2017, which is 75.00% up from last year.
  • Fortress Biotech's Depreciation & Amortization - Total amounted to $548,000 in Q3 2018, which was up 17.60% from $466,000 recorded in Q2 2018.
  • Fortress Biotech's Depreciation & Amortization - Total's 5-year high stood at $548,000 during Q3 2018, with a 5-year trough of -$119,000 in Q4 2017.
  • For the 3-year period, Fortress Biotech's Depreciation & Amortization - Total averaged around $199,636, with its median value being $180,000 (2017).
  • Over the last 5 years, Fortress Biotech's Depreciation & Amortization - Total had its largest YoY gain of 6,750.00% in 2017, and its largest YoY loss of 174.38% in 2017.
  • Fortress Biotech's Depreciation & Amortization - Total (Quarterly) stood at $160,000 in 2016, then tumbled by 174.38% to -$119,000 in 2017, then soared by 174.00% to $548,000 in 2018.
  • Its Depreciation & Amortization - Total stands at $548,000 for Q3 2018, versus $466,000 for Q2 2018 and $365,000 for Q1 2018.